PCV19 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL HIP AND KNEE REPLACEMENT (THR, TKR) IN CHINESE PATIENTS
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73146-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)73146-1/fulltext
Title :
PCV19 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL HIP AND KNEE REPLACEMENT (THR, TKR) IN CHINESE PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73146-1&doi=10.1016/S1098-3015(11)73146-1
First page :
A520
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1306